Your browser doesn't support javascript.
loading
Prognostic relevance of molecular measurable residual disease detection in AML with mutated CEBPA.
Vonk, Christian M; Boertjes, Emma L; Kavelaars, Francois G; Rijken, Melissa; Konijnenburg, Jolinda M L; Cromwell, Roxanne E; Löwenberg, Bob; Grob, Tim; Valk, Peter J M.
Affiliation
  • Vonk CM; Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands.
  • Boertjes EL; Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands.
  • Kavelaars FG; Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands.
  • Rijken M; Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands.
  • Konijnenburg JML; Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands.
  • Cromwell RE; Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands.
  • Löwenberg B; Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands.
  • Grob T; Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands.
  • Valk PJM; Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands.
Hemasphere ; 8(8): e141, 2024 Aug.
Article in En | MEDLINE | ID: mdl-39148661

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hemasphere Year: 2024 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hemasphere Year: 2024 Document type: Article Country of publication: United States